Regenerat3D aims to provide a custom-made tissue service for researchers. As the demand for organ donors increases, the need for an alternative source of organ tissue rises. Instead of having to wait on the donor list or having to use animals for testing, researchers will be able to purchase custom-made organ tissue structures at a low price. Expect public demonstrations and published research to come your way as we refine our tissue synthesis technology. Here at Regenerat3D, the customer is our top priority; each customer will be assigned a Regenerat3D representative to help guide their journey into synthetic organs.

 

Commercialization Timeline:

• Refine prototype: Optimize cell implantation and culturing strategies

• Secure Funding: angel investors, SBIR/STTR grants, NIH grant, etc.

• Biocompatibility testing: Perform testing per ISO 8637:2004

• Complete final product: Build marketable iteration of first synthetic organ

• Publish research results in an effort to bring transparency to our customers

• Conduct clinical trials to validate patient satisfaction with synthetic organ

• Clinical trial comparisons: comparing our technology with competitors

• Product release: Launch of our artificial organ to the research market